[ET Net News Agency, 3 July 2024] JD HEALTH (06618) rose 4.8% to HK$21.95.
It hits an intra-day high of HK$22, and an intra-day low of HK$20.9. The total shares
traded was 3.84 million, with a value of HK$82m. The active buy/sell ratio is 60:40, with
net buying turnover of HK$15.36m. CITIGROUP GLOBAL accounts for greatest net responsive
buying turnover of HK$3.7m, with volume weighted average price of HK$21.328. CHINA
INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$7.06m,
with volume weighted average price of HK$21.383.
RMB counter of JD HEALTH (86618) rose 4.1% to RMB20.5. It hits an intra-day high of
RMB19.86, and an intra-day low of RMB19.86. The total shares traded was 450, with a value
of RMB8,937.
The Hang Seng Index now rose 238 points, or 1.3% to 18,008; the Hang Seng China
Enterprises Index now rose 88 points, or 1.4% to 6,463; the Hang Seng TECH Index now rose
95 points, or 2.7% to 3,634.

Basic Information
=================

---------------------------------
Nominal 21.950 % Chg +4.77%
High 22.000 Low 20.900
Shares Tr 3.84m Turnover 82m
10-D SMA 22.575 %H.V 32.717
20-D SMA 23.890 VWAP 21.357
50-D SMA 26.302 RSI14 33.505
---------------------------------
Status: Active buy/sell ratio is 60:40, with net buying turnover of HK$15.36m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 21.95 +4.77
ALI HEALTH (00241) 3.22 +3.87
TRAD CHI MED (00570) 3.73 +2.19
CSPC PHARMA (01093) 6.26 +0.16
SINOPHARM (01099) 21.00 +0.96
SINO BIOPHARM (01177) 2.75 +1.85
CHINARES PHARMA (03320) 5.79 +0.70
HANSOH PHARMA (03692) 16.16 +1.76
GOLDEN THROAT (06896) 3.08 Unchanged
JD HEALTH-R (86618) RMB20.50 +4.06
-----------------------------------------------
(ed)